Capital One National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

Capital One National Association’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$379K	Sell	2,229 -247	-10%	-$38.3K	0.03%	373
2018 Q1	$404K	Sell	2,476 -68	-3%	-$11.1K	0.03%	376
2017 Q4	$381K	Sell	2,544 -118	-4%	-$17.5K	0.03%	399
2017 Q3	$405K	Sell	2,662 -233	-8%	-$35.1K	0.03%	386
2017 Q2	$373K	Sell	2,895 -24	-0.8%	-$2.89K	0.03%	386
2017 Q1	$319K	Sell	2,919 -353	-11%	-$31.1K	0.02%	421
2016 Q4	$241K	Sell	3,272 -61	-2%	-$4.96K	0.02%	453
2016 Q3	$291K	Buy	3,333 +90	+3%	+$8.51K	0.02%	430
2016 Q2	$279K	Sell	3,243 -44	-1%	-$3.8K	0.02%	433
2016 Q1	$261K	Sell	3,287 -2,235	-40%	-$202K	0.02%	454
2015 Q4	$695K	Sell	5,522 -275	-5%	-$33.2K	0.06%	280
2015 Q3	$603K	Sell	5,797 -591	-9%	-$75.9K	0.06%	299
2015 Q2	$789K	Buy	6,388 +327	+5%	+$41.2K	0.07%	263
2015 Q1	$715K	Sell	6,061 -3,700	-38%	-$443K	0.06%	289
2014 Q4	$1.16M	Sell	9,761 -2,753	-22%	-$310K	0.11%	216
2014 Q3	$1.41M	Sell	12,514 -491	-4%	-$46.7K	0.14%	176
2014 Q2	$1.23M	Sell	13,005 -2,594	-17%	-$182K	0.12%	205
2014 Q1	$1.1M	Sell	15,599 -2,442	-14%	-$193K	0.11%	222
2013 Q4	$1.34M	Sell	18,041 -8,994	-33%	-$626K	0.13%	197
2013 Q3	$2.05M	Sell	27,035 -2,397	-8%	-$191K	0.21%	140
2013 Q2	$2.36M	Buy	+29,432	New	+$2.17M	0.25%	119

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Capital One National Association's VRTX Position: Q2 2018 in Review

Capital One National Association reduced its Vertex Pharmaceuticals (VRTX) stake by 10% in Q2 2018, selling an estimated $38.3K and leaving 2,229 shares worth $379K. The position accounts for 0.03% of the portfolio, ranked #373.

Capital One National Association first reported a position in VRTX in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.36M in Q2 2013. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

Capital One National Association held 2,229 shares of Vertex Pharmaceuticals worth $379K as of Q2 2018.
Capital One National Association sold 247 Vertex Pharmaceuticals shares in Q2 2018, an estimated $38.3K.
Vertex Pharmaceuticals made up 0.03% of Capital One National Association's portfolio in Q2 2018, its #373 holding.
Capital One National Association first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
Capital One National Association's Vertex Pharmaceuticals position peaked at $2.36M in Q2 2013.
690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.